Rahsaan Thompson | General Counsel |
Roger Crystal | CEO |
David O'Toole | CFO |
David Bautz | Zacks |
Carl Byrnes | Northland Capital |
Greetings, and welcome to the Opiant Pharmaceuticals Third Quarter 2019 Earnings Conference Call. At this all participants are in a listen-only mode. A brief question and answer session will follow the formal presentation [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Rahsaan Thompson, General Counsel of Opiant Pharmaceuticals. Thank you Rahsaan, you may begin.